AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17454589 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐IFNalpha‐2a, 450 microg once weekly
Number of subjects: 144
Study 17454589 — intervention group
Group type: COMPARATOR
Intervention: IFNalpha‐2a, 9 MIU once daily
Number of subjects: 144
Study 15157126 — intervention group
Group type: EXPERIMENTAL
Intervention: Music/Video
Number of subjects: 86
Study 15157126 — intervention group
Group type: EXPERIMENTAL
Intervention: Music-Only
Number of subjects: 86
Study 15157126 — intervention group
Group type: COMPARATOR
Intervention: Video-Only
Number of subjects: 86
Study 15157126 — intervention group
Group type: COMPARATOR
Intervention: No contact Control
Number of subjects: 86
Study 12414849 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/d micronized E(2) (n = 12)
Number of subjects: 26
Study 12414849 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL; n = 13)
Number of subjects: 26
Study 9466049 — intervention group
Group type: EXPERIMENTAL
Intervention: 13-cis-retinoic acid (1 mg/kg/day)
Number of subjects: 73
Study 9466049 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 7857585 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol and ridazolol (beta-adrenoreceptor blockers)
Number of subjects: 42
Study 2563608 — intervention group
Group type: EXPERIMENTAL
Intervention: VDU with strong electrostatic and electromagnetic fields
Number of subjects: 30
Study 2563608 — intervention group
Group type: COMPARATOR
Intervention: VDU with eliminated electrostatic and electromagnetic fields
Number of subjects: 30
Study 2563608 — intervention group
Group type: COMPARATOR
Intervention: VDU turned off (with cable present)
Number of subjects: 30
Study 26 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg Sch 1000
Number of subjects: 12
Study 26 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg Sch 1000 + 10 mg oxazepam
Number of subjects: 12
Study 26 — intervention group
Group type: COMPARATOR
Intervention: 10 mg oxazepam
Number of subjects: 12
Study 26 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30819238 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based personalised information and support system (WINS) (n = 53)
Number of subjects: 102
Study 30819238 — intervention group
Group type: COMPARATOR
Intervention: Standard care (n = 49)
Number of subjects: 102
Study 28822837 — intervention group
Group type: COMPARATOR
Intervention: Active tDCS treatment in Phase II
Number of subjects: 42
Study 28822837 — intervention group
Group type: COMPARATOR
Intervention: Active tDCS treatment in Phase I
Number of subjects: 42
Study 25897156 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil (5 mg for 6 weeks, 10 mg for 18 weeks)
Number of subjects: 198
Study 25897156 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 198
Study 24311553 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal counselling
Number of subjects: 0
Study 24311553 — intervention group
Group type: COMPARATOR
Intervention: Selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 0
Study 21981869 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy using acupressure therapy, hypnotherapy, and transcendental meditation (TM)
Number of subjects: 20
Study 21981869 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 capsules containing 3g of wheat flour each, taken morning and evening)
Number of subjects: 20
Study 19019594 — intervention group
Group type: EXPERIMENTAL
Intervention: TASER X26 (5-s exposure)
Number of subjects: 4
Study 19019594 — intervention group
Group type: EXPERIMENTAL
Intervention: Oleoresin capsicum (O.C.) (5-s spray to the eyes)
Number of subjects: 4
Study 19019594 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-water immersion (45-s exposure of hand and forearm in 0 degrees C)
Number of subjects: 4
Study 19019594 — intervention group
Group type: EXPERIMENTAL
Intervention: Defensive tactics drill (1-min drill)
Number of subjects: 4
Study 17200238 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri (10^8 live bacteria per day)
Number of subjects: 90
Study 17200238 — intervention group
Group type: COMPARATOR
Intervention: Simethicone (60 mg/day)
Number of subjects: 90
Study 15377853 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective burden before adjuvant therapy
Number of subjects: 239
Study 15377853 — intervention group
Group type: EXPERIMENTAL
Intervention: Better mood
Number of subjects: 239
Study 15377853 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradient of beta2‐microglobulin
Number of subjects: 239
Study 15377853 — intervention group
Group type: EXPERIMENTAL
Intervention: Markers of activation of the cellular immune system
Number of subjects: 239
Study 11865786 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA anesthetic cream applied for 15 minutes
Number of subjects: 48
Study 11865786 — intervention group
Group type: COMPARATOR
Intervention: EMLA anesthetic cream applied for 30 minutes
Number of subjects: 48
Study 9560034 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholestatic infants
Number of subjects: 34
Study 9560034 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfed cholestatic infants
Number of subjects: 34
Study 8163732 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/kg DMSA for 14 days
Number of subjects: 20
Study 8163732 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 14 days
Number of subjects: 20
Study 8163732 — intervention group
Group type: EXPERIMENTAL
Intervention: DMSA treatment
Number of subjects: 20
Study 2828406 — intervention group
Group type: EXPERIMENTAL
Intervention: RU 486 (20 mg/kg)
Number of subjects: 10
Study 2828406 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol (0.1 mg/kg)
Number of subjects: 10
Study 2828406 — intervention group
Group type: EXPERIMENTAL
Intervention: RU 486 and cortisol combination
Number of subjects: 10
Study 2828406 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31899253 — intervention group
Group type: EXPERIMENTAL
Intervention: FCCH-based intervention (9-month duration, delivered through three workshops, three home visits, and nine phone calls)
Number of subjects: 496
Study 31899253 — intervention group
Group type: COMPARATOR
Intervention: Attention control arm (business-focused intervention)
Number of subjects: 496
Study 31899253 — intervention group
Group type: EXPERIMENTAL
Intervention: FCCH-based intervention
Number of subjects: 496
Study 31125335 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian Representational Similarity Analysis (BRSA)
Number of subjects: 0
Study 31125335 — intervention group
Group type: COMPARATOR
Intervention: Pattern Component Model (PCM)
Number of subjects: 0
Study 28380151 — intervention group
Group type: EXPERIMENTAL
Intervention: Hammock position
Number of subjects: 30
Study 28380151 — intervention group
Group type: COMPARATOR
Intervention: Nesting
Number of subjects: 30
Study 25840429 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol (400 mcg) 1 hour prior to surgery
Number of subjects: 184
Study 25840429 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol (400 mcg) 3 hours prior to surgery
Number of subjects: 184
Study 25840429 — intervention group
Group type: COMPARATOR
Intervention: Vaginal misoprostol (400 mcg) 1 hour prior to surgery
Number of subjects: 184
Study 25840429 — intervention group
Group type: COMPARATOR
Intervention: Vaginal misoprostol (400 mcg) 3 hours prior to surgery
Number of subjects: 184
Study 25840429 — intervention group
Group type: EXPERIMENTAL
Intervention: Total priming time
Number of subjects: 184
Study 25840429 — intervention group
Group type: EXPERIMENTAL
Intervention: Administration route
Number of subjects: 184
Study 25840429 — intervention group
Group type: EXPERIMENTAL
Intervention: Administration route and priming time interaction
Number of subjects: 184
Study 25840429 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of surgery
Number of subjects: 184
Study 25840429 — intervention group
Group type: EXPERIMENTAL
Intervention: Amount of bleeding
Number of subjects: 184
Study 25840429 — intervention group
Group type: EXPERIMENTAL
Intervention: Rate of side effects (nausea, shivering)
Number of subjects: 184
Study 23920419 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon dilation
Number of subjects: 92
Study 23920419 — intervention group
Group type: COMPARATOR
Intervention: FESS
Number of subjects: 92
Study 21438891 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Atrioventricular Search Hysteresis (AVSH)
Number of subjects: 178
Study 21438891 — intervention group
Group type: COMPARATOR
Intervention: Standard Atrioventricular Search Hysteresis (AVSH)
Number of subjects: 178
Study 21438891 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Atrioventricular Search Hysteresis (AVSH) in patients with a history of AV block
Number of subjects: 178
Study 21438891 — intervention group
Group type: COMPARATOR
Intervention: Standard Atrioventricular Search Hysteresis (AVSH) in patients with a history of AV block
Number of subjects: 178
Study 21438891 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall patients experiencing > 20% relative %VP reduction
Number of subjects: 178
Study 19728565 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose combination of 135 mg amodiaquine and 50 mg artesunate administered after a high-fat breakfast
Number of subjects: 22
Study 19728565 — intervention group
Group type: COMPARATOR
Intervention: Fixed-dose combination of 135 mg amodiaquine and 50 mg artesunate administered in fasting state
Number of subjects: 22
Study 17451691 — intervention group
Group type: COMPARATOR
Intervention: hCG
Number of subjects: 228
Study 17451691 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH-agonist
Number of subjects: 228
Study 15584055 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression plus surgery
Number of subjects: 214
Study 15584055 — intervention group
Group type: COMPARATOR
Intervention: Compression alone
Number of subjects: 214
Study 11876716 — intervention group
Group type: EXPERIMENTAL
Intervention: Prucalopride
Number of subjects: 10
Study 10201465 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 80 mg q.d. and metronidazole extended‐release formulation 750 mg q.d. for 10 days (OM)
Number of subjects: 160
Study 10201465 — intervention group
Group type: EXPERIMENTAL
Intervention: OM plus amoxicillin 1.5 g q.d. for 10 days (OMAm)
Number of subjects: 160
Study 10201465 — intervention group
Group type: EXPERIMENTAL
Intervention: OM plus azithromycin 500 mg q.d. for 7 days (OMAz)
Number of subjects: 160
Study 10201465 — intervention group
Group type: EXPERIMENTAL
Intervention: OM plus clarithromycin 1 g q.d. for 10 days (OMCI)
Number of subjects: 160
Study 7575985 — intervention group
Group type: EXPERIMENTAL
Intervention: Low air loss (LAL) therapy
Number of subjects: 10
Study 7575985 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital mattress (SHM)
Number of subjects: 10
Study 2391592 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-CHO formula
Number of subjects: 12
Study 2391592 — intervention group
Group type: COMPARATOR
Intervention: High-CHO formula
Number of subjects: 12
Study 6767824 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher protein regimen of 3.6 gm/kg/day
Number of subjects: 82
Study 6767824 — intervention group
Group type: COMPARATOR
Intervention: Lower protein regimen of 2.3 gm/kg/day
Number of subjects: 82
Study 6767824 — intervention group
Group type: COMPARATOR
Intervention: Comparison of ChJ infants to long-term PN infants without ChJ
Number of subjects: 82
Study 30531184 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic plasma exchange
Number of subjects: 81
Study 30531184 — intervention group
Group type: COMPARATOR
Intervention: No therapeutic plasma exchange
Number of subjects: 81
Study 28093012 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation program (n=79)
Number of subjects: 161
Study 28093012 — intervention group
Group type: COMPARATOR
Intervention: Standard care (n=82)
Number of subjects: 161
Study 26334173 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic Sphincterotomy (EST)
Number of subjects: 255
Study 26334173 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic Papillary Large Balloon Dilation (EPLBD)
Number of subjects: 255
Study 26334173 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic Sphincterotomy plus Large Balloon Dilation (ESLBD)
Number of subjects: 255
Study 26334173 — intervention group
Group type: EXPERIMENTAL
Intervention: EPLBD
Number of subjects: 255
Study 23691837 — intervention group
Group type: EXPERIMENTAL
Intervention: Part-task training
Number of subjects: 0
Study 23691837 — intervention group
Group type: COMPARATOR
Intervention: Whole-task training
Number of subjects: 0
Study 21642610 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural lidocaine administration (20-35 mL) 1 hour before epidural EREM administration
Number of subjects: 30
Study 21642610 — intervention group
Group type: COMPARATOR
Intervention: Epidural EREM (8 mg)
Number of subjects: 30
Study 19780401 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypomagnesemia group
Number of subjects: 165
Study 19780401 — intervention group
Group type: COMPARATOR
Intervention: Normo-magnesemic group
Number of subjects: 165
Study 19780401 — intervention group
Group type: COMPARATOR
Intervention: Comparison of AUC between groups
Number of subjects: 165
Study 16930385 — intervention group
Group type: EXPERIMENTAL
Intervention: Psycho-educational program
Number of subjects: 0
Study 15568670 — intervention group
Group type: EXPERIMENTAL
Intervention: rabeprosole (pariet)
Number of subjects: 20
Study 15568670 — intervention group
Group type: EXPERIMENTAL
Intervention: omeprosole (omez)
Number of subjects: 20
Study 11295623 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium (200 microg/day in selenized yeast)
Number of subjects: 0
Study 11295623 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium
Number of subjects: 0
Study 9155504 — intervention group
Group type: EXPERIMENTAL
Intervention: High-MUFA meal (24% energy)
Number of subjects: 15
Study 9155504 — intervention group
Group type: COMPARATOR
Intervention: Low-MUFA meal (12% energy)
Number of subjects: 15
Study 9155504 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-MUFA meal (17% energy)
Number of subjects: 15
Study 7681997 — intervention group
Group type: EXPERIMENTAL
Intervention: 18 Gy/3 fractions/3 days
Number of subjects: 216
Study 7681997 — intervention group
Group type: COMPARATOR
Intervention: 25 Gy/10 fractions/14 days (second course)
Number of subjects: 216
Study 3595691 — intervention group
Group type: EXPERIMENTAL
Intervention: Ifosfamide (IFOS) 5 g/m2
Number of subjects: 171
Study 3595691 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide (CYCLO) 1.5 g/m2
Number of subjects: 171
Study 3595691 — intervention group
Group type: EXPERIMENTAL
Intervention: Ifosfamide (IFOS)
Number of subjects: 171
Study 3595691 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide (CYCLO)
Number of subjects: 171
Study 3595691 — intervention group
Group type: EXPERIMENTAL
Intervention: Ifosfamide (IFOS) and Cyclophosphamide (CYCLO)
Number of subjects: 171
Study 29436078 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisensory exercise programme (n = 24)
Number of subjects: 45
Study 29436078 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 21)
Number of subjects: 45
Study 26331711 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-ESD eradication therapy (n = 44)
Number of subjects: 96
Study 26331711 — intervention group
Group type: COMPARATOR
Intervention: Post-ESD eradication therapy (n = 52)
Number of subjects: 96
Study 24721289 — intervention group
Group type: EXPERIMENTAL
Intervention: Food advertising
Number of subjects: 351
Study 24721289 — intervention group
Group type: EXPERIMENTAL
Intervention: High cognitive load with food advertising
Number of subjects: 351
Study 24721289 — intervention group
Group type: COMPARATOR
Intervention: Non-food advertising
Number of subjects: 351
Study 24721289 — intervention group
Group type: COMPARATOR
Intervention: Low cognitive load
Number of subjects: 351
Study 23113531 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental Group (EG) - reduced hoop diameter rim (0.35 m)
Number of subjects: 18
Study 23113531 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - standard rim
Number of subjects: 18
Study 21738668 — intervention group
Group type: EXPERIMENTAL
Intervention: sequential 2, 4 and 8‐week ART interruptions
Number of subjects: 53
Study 21738668 — intervention group
Group type: COMPARATOR
Intervention: continuous ART (cART)
Number of subjects: 53
Study 20049658 — intervention group
Group type: EXPERIMENTAL
Intervention: UV photography and skin cancer information intervention
Number of subjects: 148
Study 20049658 — intervention group
Group type: EXPERIMENTAL
Intervention: UV photography and photoaging information intervention
Number of subjects: 148
Study 20049658 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 148
Study 16566623 — intervention group
Group type: EXPERIMENTAL
Intervention: EX/RP+CMI
Number of subjects: 122
Study 16566623 — intervention group
Group type: EXPERIMENTAL
Intervention: EX/RP
Number of subjects: 122
Study 16566623 — intervention group
Group type: EXPERIMENTAL
Intervention: CMI
Number of subjects: 122
Study 16566623 — intervention group
Group type: COMPARATOR
Intervention: PBO
Number of subjects: 122
Study 12770651 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative and postoperative administration of atenolol
Number of subjects: 59
Study 12770651 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative atenolol as a major component of the anesthetic regimen
Number of subjects: 59
Study 12770651 — intervention group
Group type: COMPARATOR
Intervention: Perioperative management without beta‐adrenergic antagonism
Number of subjects: 59
Study 10894377 — intervention group
Group type: EXPERIMENTAL
Intervention: Core decompression (surgical treatment)
Number of subjects: 9
Study 10894377 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment (control group)
Number of subjects: 9
Study 9298605 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.02% benzalkonium chloride
Number of subjects: 65
Study 9298605 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 65
Study 9298605 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate aqueous nasal spray
Number of subjects: 65
Study 9298605 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.02% benzalkonium chloride without fluticasone)
Number of subjects: 65
Study 8336255 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd:YAG laser irradiation (20 W for 0.3, 0.5, 1.0, 2.0, or 3.0 seconds)
Number of subjects: 15
Study 8336255 — intervention group
Group type: COMPARATOR
Intervention: Citric acid treatment (saturated, pH 1 for 3 minutes)
Number of subjects: 15
Study 3342628 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol cleansing followed by application of an iodophor‐impregnated sterile film
Number of subjects: 60
Study 3342628 — intervention group
Group type: COMPARATOR
Intervention: Traditional iodophor skin cleansing
Number of subjects: 60
Study 29193548 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-hospital blood product (PHBP) administration (up to two units of red blood cells and two units of lyophilised plasma)
Number of subjects: 490
Study 29193548 — intervention group
Group type: COMPARATOR
Intervention: Standard care (up to four boluses of 250 mL 0.9% saline)
Number of subjects: 490
Study 29193548 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-hospital blood product (PHBP) administration
Number of subjects: 490
Study 26794694 — intervention group
Group type: EXPERIMENTAL
Intervention: Pd‐Ag‐In alloy crowns
Number of subjects: 35
Study 26794694 — intervention group
Group type: COMPARATOR
Intervention: Gold alloy crowns
Number of subjects: 35
Study 26794694 — intervention group
Group type: COMPARATOR
Intervention: Zirconia crowns
Number of subjects: 35
Study 25611944 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral weight loss intervention (≥5% weight loss)
Number of subjects: 390
Study 23746429 — intervention group
Group type: EXPERIMENTAL
Intervention: E-cigarette use
Number of subjects: 4444
Study 21969577 — intervention group
Group type: COMPARATOR
Intervention: H2A histone family, member Y (H2AFY) overexpression in blood and frontal cortex of HD patients
Number of subjects: 119
Study 21969577 — intervention group
Group type: EXPERIMENTAL
Intervention: Histone deacetylase inhibitor
Number of subjects: 119
Study 18359746 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 61
Study 18359746 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 61
Study 18359746 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 61
Study 18359746 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 2 diabetics
Number of subjects: 61
Study 16437275 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Simulator (SIMENDO)
Number of subjects: 75
Study 16437275 — intervention group
Group type: COMPARATOR
Intervention: Conventional Box Trainer
Number of subjects: 75
Study 16437275 — intervention group
Group type: EXPERIMENTAL
Intervention: Experts (>100 endoscopic procedures)
Number of subjects: 75
Study 16437275 — intervention group
Group type: COMPARATOR
Intervention: Novices (no experience)
Number of subjects: 75
Study 12641642 — intervention group
Group type: EXPERIMENTAL
Intervention: Kistler 9861A force platform (KIS)
Number of subjects: 29
Study 12641642 — intervention group
Group type: EXPERIMENTAL
Intervention: Chattecx Balance System (CBS)
Number of subjects: 29
Study 10572797 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate and topical dexamethasone (n = 34)
Number of subjects: 56
Study 10572797 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone ointment (n = 22)
Number of subjects: 56
Study 9065279 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative hormone therapy
Number of subjects: 7
Study 9065279 — intervention group
Group type: COMPARATOR
Intervention: No preoperative hormone therapy (Control)
Number of subjects: 7
Study 1860293 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical varnish containing strontium chloride
Number of subjects: 10
Study 1860293 — intervention group
Group type: COMPARATOR
Intervention: Varnish application with no active ingredient (placebo)
Number of subjects: 10
Study 1860293 — intervention group
Group type: COMPARATOR
Intervention: Untreated teeth
Number of subjects: 10
Study 6751143 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide
Number of subjects: 0
Study 6751143 — intervention group
Group type: COMPARATOR
Intervention: Positive pressure ventilation with a bag and mask
Number of subjects: 0